Tag: Novo

Novo Nordisk (NVO -1.69%), known for its GLP-1 weight loss drugs Ozempic and Wegovy, saw a 2% decline after Reuters ...

Danish drugmaker Novo Nordisk presented its annual report in Bagsvaerd, Denmark, showcasing flags with the company's logos, including those of ...

Novo Nordisk defended disappointing trial results for its obesity drug candidate CagriSema, emphasizing its importance as a weight loss treatment ...

Danish drugmaker Novo Nordisk showcased flags featuring the logos of their popular diabetes and weight-loss treatments Ozempic and Wegovy during ...

Novo Nordisk's hopes of revolutionizing obesity treatment with its CagriSema drug have been cast into doubt following disappointing trial results, ...

Shares of Novo Nordisk rose 4.5% after reporting a better-than-expected net profit in the fourth quarter, driven by strong demand ...

Shares of Novo Nordisk surged 10% following positive early-stage results for its once weekly amycretin obesity drug, which led to ...

Novo Nordisk shares plummeted 24% in London trading after its weight-loss drug CagriSema fell short of expectations, inducing a 22.7% ...

Shares of Novo Nordisk dropped over 24% after disappointing results in a trial for its CagriSema weight loss drug, which ...

A pair of late-stage trials conducted by Eli Lilly found that their experimental once-weekly insulin can effectively lower blood sugar ...